NEWS SUMMARY: CAF, INDRA, NATURGY. The FED cut rates, as expected With the Ibex remaining near highs, the lack of definition continued for European stock markets, awaiting the Fed’s decision. In the STOXX 600, Basic Resources and Banks led the gains whereas Autos and Construction (after an equity research firm cut Vinci’s recommendation) were the worst performers. On the macro side, in the US, as expected, the Fed cut interest rates by 25bps to 3.5%-3.75% (with 1 member in favour of cutting -5...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, INDRA, NATURGY. EUROPA: MUNICH RE. La FED cumple con el recorte de tipos Con el Ibex manteniéndose cerca de sus máximos las bolsas europeas continuaron una jornada más con cierta indefinición a la espera de catalizadores. En el STOXX 600, los mejores sectores fueron R. Básicos y Bancos mientras que Autos y Construcción (afectado por la rebaja de recomendación a Vinci por parte de una casa de análisis) fueron los que más cayeron. Por el lado m...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACERINOX, SECTOR ELÉCTRICO, SOLARIA. EUROPA: SOCIÉTÉ GÉNÉRALE. Las bolsas siguen dudando de las valoraciones en torno a la IA La semana comenzó con descensos, tal y como terminó la anterior, lastrada por la incertidumbre sobre la decisión de tipos de la Fed en diciembre y por el creciente temor a una burbuja en torno a la inteligencia artificial. El Ibex 35 acumuló su tercera sesión consecutiva de caídas y perdió los 16.200 puntos. En el STOXX 600, ...
NEWS SUMMARY: ACERINOX, ELECTRICITY SECTOR, SOLARIA. Valuations on AI continue to raise doubts on stock markets The week kicked off with drops (as the previous one ended), dragged down by the uncertainty surrounding the Fed’s decision on rates in December and by the growing fear of an AI bubble. The IBEX 35 fell for the third straight day, closing below 16,200. In the STOXX 600, most sectors ended with drops, led by Retail and Chemicals, whereas Utilities and Energy ended as the best relative p...
3Q'25 vs. 3Q'24 Results Sales: € 986.0 M (+17.7% vs. +10.0% BS(e) and +12.6% consensus); EBIT: € 47.0 M (+34.3% vs. +37.7% BS(e) and +42.9% consensus); Net Profit: € 27.0 M (+200.0% vs. +173.3% BS(e) and +211.1% consensus); 9M'25 vs. 9M'24 Results Sales: € 3.165 Bn (+8.5% vs. +6.3% BS(e) and +7.0% consensus); EBIT: € 161.0 M (+17.5% vs. +18.4% BS(e) and +19.7% consensus); Net Profit: € 100.0 M (+63.9% vs. +60.0% BS(e) and +65.6% consensus);
3Q’25 vs. 3Q’24: Sales: € 180.9 M (-17.6% vs. -16.5% BS(e)); EBITDA: € 12.7 M (-75.4% vs. -79.1% BS(e)); EBIT: € -11.1 M (€ 26.1 M in 9M’24 vs. € -13.2 M BS(e)); Net Profit: € -15.1 M (€ 14.3 M in 9M’24 vs. € -17.7 M BS(e)). 9M’25 vs. 9M’24: Sales: € 560.1 M (-16.2% vs. -15.8% BS(e)); EBITDA: € 70.7 M (-53.6% vs. -54.9% BS(e)); EBIT: € -1.1 M (€ 71.1 M in 9M’24 vs. € -3.2 M BS(e)); Net Profit: € -22.0 M (€ 40.8 M in 9M’24 vs. € -24.6 M BS(e)).
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.